Evidence map›Paper›PMID 42806097›Full record

ReviewNature reviews. Neurology2026

Use of MRI in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease - MAGNIMS consensus recommendations.

Rosa Cortese, Yael Hacohen, Georgina Arrambide, Alessia Bianchi, Gabriele DeLuca, Massimo Filippi, Claudio Gasperini, Ruth Geraldes, Cristina Granziera, Lukas Haider and 13 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Rosa CorteseDepartment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.ORCID http://orcid.org/0000-0002-9803-7914
Yael HacohenDepartment of Neurology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Georgina ArrambideNeurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2657-5510
Alessia BianchiDepartment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Gabriele DeLucaNuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK.ORCID http://orcid.org/0000-0003-0342-5197
Massimo FilippiNeuroimaging Research Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID http://orcid.org/0000-0002-5485-0479
Claudio GasperiniDepartment of Neurosciences, S. Camillo-Forlanini Hospital, Rome, Italy.ORCID http://orcid.org/0000-0002-3959-4067
Ruth GeraldesNuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK.
Cristina GranzieraTranslational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-4917-8761
Lukas HaiderComprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Silvia MessinaNuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK.
Jaume Sastre-GarrigaNeurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1589-2254
Paolo PreziosaNeuroimaging Research Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID http://orcid.org/0000-0002-7826-0019
Maria Assunta RoccaNeuroimaging Research Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID http://orcid.org/0000-0003-2358-4320
Àlex RoviraSection of Neuroradiology, Department of Radiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2132-6750
Mar TintoréNeurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-9999-5359
Ahmed ToosyQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, London, UK.ORCID http://orcid.org/0000-0002-4441-3750
Carla TortorellaDepartment of Neurosciences, S. Camillo-Forlanini Hospital, Rome, Italy.
Manuela VaneckovaDepartment of Radiology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-8784-7997
Tarek YousryNeuroradiological Academic Unit, UCL Queen Square Institute of Neurology, University College London, London, UK.
Jacqueline PalaceNuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK.ORCID http://orcid.org/0000-0003-4779-6133
Nicola De StefanoDepartment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy. destefano@unisi.it.
MAGNIMS Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aquaporin 4-positive neuromyelitis optica spectrum disorder (AQP4

Identifiers

PMID42806097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.